Research - Oxford, England, United Kingdom
An Oxford University biotech spinout, and an innovative collaboration between Immunology, Vaccine and Oncology experts. Exploiting a CRUK-patented vaccine with excellent preclinical results. The venture has been funded to advance the technology into phase I/IIa clinical trials.
Outlook
Nginx
WordPress.org
Google Tag Manager
Microsoft Office 365
Google Cloud Hosting